These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 2956273)
1. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography. Gilman S; Markel DS; Koeppe RA; Junck L; Kluin KJ; Gebarski SS; Hichwa RD Ann Neurol; 1988 Mar; 23(3):223-30. PubMed ID: 3259853 [TBL] [Abstract][Full Text] [Related]
2. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165 [TBL] [Abstract][Full Text] [Related]
3. [The aging of the brain studied with PET, MRI and X-ray CT]. Fukuyama H; Shio H Nihon Ronen Igakkai Zasshi; 1987 Mar; 24(2):105-9. PubMed ID: 3498058 [No Abstract] [Full Text] [Related]
4. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography. Leenders KL; Frackowiak RS; Quinn N; Marsden CD Mov Disord; 1986; 1(1):69-77. PubMed ID: 2973559 [TBL] [Abstract][Full Text] [Related]
5. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia]. Okada J; Peppard R; Calne DB Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056 [TBL] [Abstract][Full Text] [Related]
6. Quantitative comparison of the bolus and steady-state methods for measurement of cerebral perfusion and oxygen metabolism: positron emission tomography study using 15O-gas and water. Okazawa H; Yamauchi H; Sugimoto K; Takahashi M; Toyoda H; Kishibe Y; Shio H J Cereb Blood Flow Metab; 2001 Jul; 21(7):793-803. PubMed ID: 11435791 [TBL] [Abstract][Full Text] [Related]
7. Regional correction of positron emission tomography data for the effects of cerebral atrophy. Videen TO; Perlmutter JS; Mintun MA; Raichle ME J Cereb Blood Flow Metab; 1988 Oct; 8(5):662-70. PubMed ID: 3262114 [TBL] [Abstract][Full Text] [Related]
9. A quantitative study of physiological cerebral atrophy with aging. A statistical analysis of the normal range. Nagata K; Basugi N; Fukushima T; Tango T; Suzuki I; Kaminuma T; Kurashina S Neuroradiology; 1987; 29(4):327-32. PubMed ID: 3627412 [TBL] [Abstract][Full Text] [Related]
10. The necessity for correcting for cerebral atrophy in global positron emission tomography measurements. Herscovitch P; Gado M; Mintun MA; Raichle ME Monogr Neural Sci; 1984; 11():93-7. PubMed ID: 6610826 [No Abstract] [Full Text] [Related]
11. [Metabolic, cerebral and neuropsychological characterization of Parkinson syndromes]. Salmon E; Van der Linden M; Garraux G; Collette F; Demoulin V; George M; Franck G Rev Med Liege; 1996 Sep; 51(9):566-70. PubMed ID: 8966402 [No Abstract] [Full Text] [Related]
17. Controlling for cerebral atrophy in positron emission tomography data. Clark C; Hayden M; Hollenberg S; Li D; Stoessl AJ J Cereb Blood Flow Metab; 1987 Aug; 7(4):510-2. PubMed ID: 2956273 [TBL] [Abstract][Full Text] [Related]
18. Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy. Ibáñez V; Pietrini P; Furey ML; Alexander GE; Millet P; Bokde AL; Teichberg D; Schapiro MB; Horwitz B; Rapoport SI Brain Res Bull; 2004 Mar; 63(2):147-54. PubMed ID: 15130704 [TBL] [Abstract][Full Text] [Related]